查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1951894

經皮醫用貼片市場分析及預測（至2035年）：類型、產品、技術、應用、材料類型、最終用戶、組件、製程和功能

Transdermal Medical Patch Market Analysis and Forecast to 2035: Type, Product, Technology, Application, Material Type, End User, Component, Process, Functionality
出版日期: | 出版商: Global Insight Services | 英文 338 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計經皮醫用貼片市場將從2024年的90億美元成長到2034年的177億美元，複合年成長率約為7.4%。經皮醫用貼片市場涵蓋透過皮膚給藥的黏性貼劑，可實現非侵入性且可控的藥物釋放。這些貼片用於疼痛管理、荷爾蒙補充療法和戒菸療法。推動市場成長的因素包括：患者對便捷給藥方式的需求、慢性病盛行率的上升、貼片技術的進步。專注於提高生物利用度、實現藥物緩釋以及與數位健康解決方案整合的創新技術為市場成長提供了機會。

受非侵入性給藥系統需求不斷成長的推動，經皮貼片市場預計將迎來顯著成長。其中，疼痛管理貼片市場正成為成長最快的細分市場，這主要得益於慢性疼痛病例的增加以及對有效止痛方案的需求。荷爾蒙貼劑，尤其是荷爾蒙補充療法貼劑，是成長第二快的細分市場，反映出人們對荷爾蒙療法的認知度和接受度不斷提高。尼古丁貼劑市場持續保持強勁成長勢頭，主要得益於戒菸計劃和日益增強的健康意識。採用微針技術的先進貼片因其更高的藥物輸送效率和患者依從性而備受關注。貼片材料和藥物配方的創新正在推動市場發展。個人化醫療的趨勢正在推動客製化貼片的研發，以滿足不同患者的個人化需求。此外，市場也朝著多藥貼片發展，這類貼片能夠提供全面的治療方案，並有望提高患者的依從性。

市場區隔
類型 單層含藥黏合劑、多層含藥黏合劑、儲藥型、基質型、蒸氣貼片
產品 尼古丁貼片、止痛貼片、荷爾蒙貼片、心血管貼片、神經系統貼片
科技 電穿孔、離子導入、微針、熱消融、超音波
目的 疼痛管理、荷爾蒙補充療法、戒菸支持、神經系統疾病、心血管疾病
材料類型 聚合物、丙烯酸酯、矽酮、聚異丁烯
最終用戶 醫院、診所、居家醫療機構和門診手術中心
成分 黏合劑、背襯層、藥物層、離型紙
流程 生產、包裝、品管、分銷
功能 持續、持續、即時釋

隨著市場佔有率和定價策略的不斷演變，經皮醫用貼片市場正經歷著動態變化。現有企業正積極推出創新產品以掌握新的市場機會。在技​​術進步和消費者對高效給藥系統需求的推動下，市場競爭格局正在重塑市場。新產品專注於提高治療效果和患者依從性，從而推動市場成長。慢性病盛行率的上升進一步刺激了市場需求，使該領域成為熱門投資方向。在競爭標竿分析方面，主要產業參與者正透過策略聯盟和研發投資尋求差異化優勢。監管影響至關重要，嚴格的指導方針規範產品開發和市場准入。北美和歐洲的監管標準影響全球市場趨勢。亞太地區的新興市場，在放鬆管制和醫療費用支出成長的推動下，蘊藏著盈利的發展機會。市場參與企業正專注於創新和合規，以維持成長，並利用這些趨勢獲得競爭優勢。

主要趨勢和促進因素：

經皮醫用貼片市場正經歷強勁成長，這主要得益於技術進步和對非侵入性給藥系統日益成長的需求。關鍵趨勢包括開發具有增強滲透性和緩釋機制的貼劑，從而提高患者依從性和治療效果。微針和離子導入技術在貼片設計上的應用也日益普及，使得更多種類的藥物得以輸送。糖尿病和心血管疾病等慢性病的盛行率不斷上升，需要持續且可控的藥物治療，這進一步推動了市場成長。老年人口的成長，以及他們更傾向於無痛便捷的治療方法，也進一步促進了市場擴張。此外，個人化醫療的趨勢推動了針對個別患者需求客製化貼片的研發，從而有助於改善治療效果。新興市場蘊藏著許多機遇，這些市場的醫療基礎設施正在快速發展，先進醫療技術的普及程度也不斷提高。投資研發創新貼片解決方案的公司將更有機會掌握這項不斷成長的市場需求。此外，人們越來越重視藥物的自我給藥，預計這將推動經皮吸收貼片的普及，為市場參與企業開闢盈利的途徑。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 單層含藥黏合劑
    • 多層含藥黏合劑
    • 水庫
    • 矩陣
    • 蒸發斑塊
  • 市場規模及預測：依產品分類
    • 尼古丁貼片
    • 止痛貼
    • 荷爾蒙貼片
    • 循環系統貼片
    • 神經系統補丁
  • 市場規模及預測：依技術分類
    • 電穿孔
    • 離子導入
    • 微型針
    • 熱消融
    • 超音波
  • 市場規模及預測：依應用領域分類
    • 疼痛管理
    • 荷爾蒙補充療法
    • 禁止抽煙
    • 神經系統疾病
    • 心血管疾病
  • 市場規模及預測：依材料類型分類
    • 聚合物
    • 丙烯酸纖維
    • 矽酮
    • 聚異丁烯
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 診所
    • 居家醫療環境
    • 門診手術中心
  • 市場規模及預測：依組件分類
    • 黏合劑
    • 基底材料層
    • 藥物層
    • 離型紙
  • 市場規模及預測：依製程分類
    • 製造業
    • 包裝
    • 品管
    • 分配
  • 市場規模及預測：依功能分類
    • 緩釋
    • 緩釋
    • 即時發布

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Hisamitsu Pharmaceutical
  • Mylan
  • Perrigo Company
  • Teva Pharmaceutical Industries
  • Noven Pharmaceuticals
  • Actavis
  • Endo Pharmaceuticals
  • Lohmann Therapie Systeme
  • Medherant
  • Zosano Pharma
  • Corium International
  • Duro-Med Industries
  • Nitto Denko
  • Lifescience Plus
  • Tapemark
  • Adhex Pharma
  • 4 P Therapeutics
  • Pro Solus
  • Transdermal Technologies
  • LTS Lohmann

第9章：關於我們

簡介目錄
Product Code: GIS26284

Transdermal Medical Patch Market is anticipated to expand from $9.0 billion in 2024 to $17.7 billion by 2034, growing at a CAGR of approximately 7.4%. The Transdermal Medical Patch Market encompasses adhesive patches delivering medications through the skin, offering non-invasive, controlled drug release. These patches are used for pain management, hormone replacement, and smoking cessation therapy. The market is driven by demand for patient-friendly drug delivery, rising chronic disease prevalence, and advancements in patch technology. Innovations focus on enhanced bioavailability, extended release, and integration with digital health solutions, presenting lucrative opportunities for growth.

The Transdermal Medical Patch Market is poised for substantial growth, driven by the increasing demand for non-invasive drug delivery systems. Within this market, the pain management segment emerges as the top-performing category, owing to the rising prevalence of chronic pain conditions and the demand for effective pain relief solutions. Hormonal patches, particularly in hormone replacement therapy, represent the second highest-performing segment, reflecting the growing awareness and acceptance of hormonal treatments. Nicotine patches continue to maintain significant traction, supported by smoking cessation initiatives and increasing health consciousness. Advanced patches incorporating microneedle technology are gaining attention, offering enhanced drug delivery efficiency and patient compliance. Innovations in patch materials and drug formulations further propel market opportunities. Personalized medicine trends are fostering the development of customized patches tailored to individual patient needs. The market is also witnessing a shift towards multi-drug patches, providing comprehensive treatment solutions and potentially improving patient adherence.

Market Segmentation
TypeSingle-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Reservoir, Matrix, Vapor Patch
ProductNicotine Patches, Pain Relief Patches, Hormonal Patches, Cardiovascular Patches, Neurological Patches
TechnologyElectroporation, Iontophoresis, Microneedles, Thermal Ablation, Ultrasound
ApplicationPain Management, Hormone Replacement Therapy, Smoking Cessation, Neurological Disorders, Cardiovascular Disorders
Material TypePolymer, Acrylic, Silicone, Polyisobutylene
End UserHospitals, Clinics, Home Care Settings, Ambulatory Surgical Centers
ComponentAdhesive, Backing Layer, Drug Layer, Release Liner
ProcessManufacturing, Packaging, Quality Control, Distribution
FunctionalityControlled Release, Sustained Release, Immediate Release

The Transdermal Medical Patch Market is witnessing a dynamic shift with evolving market share and pricing strategies. Established players are actively launching innovative products to capture emerging opportunities. The market is characterized by a competitive pricing landscape, influenced by technological advancements and consumer demand for efficient drug delivery systems. New product launches are focusing on enhanced therapeutic efficacy and patient compliance, driving market growth. The increasing prevalence of chronic diseases is further fueling demand, making this sector a focal point for investment. In the realm of competition benchmarking, key industry participants are differentiating through strategic collaborations and R&D investments. Regulatory influences play a pivotal role, with stringent guidelines shaping product development and market entry. North America and Europe maintain regulatory standards that impact global market dynamics. Emerging markets in Asia-Pacific present lucrative opportunities, driven by regulatory relaxation and increasing healthcare expenditure. Market players are leveraging these trends to gain competitive advantages, with a focus on innovation and regulatory compliance to sustain growth.

Geographical Overview:

The transdermal medical patch market is witnessing dynamic growth across various regions, each with unique characteristics. North America leads, driven by advanced healthcare infrastructure and increasing demand for non-invasive drug delivery systems. The region's focus on technological innovation and patient compliance propels market expansion. Europe follows, with significant investments in healthcare research and development. The region's aging population and rising chronic disease prevalence contribute to the demand for effective transdermal solutions. In Asia Pacific, the market is burgeoning due to increasing healthcare expenditures and growing awareness of advanced drug delivery methods. China and India are notable emerging markets, with rapid urbanization and expanding healthcare access. Latin America and the Middle East & Africa present promising growth pockets. Latin America benefits from improved healthcare infrastructure, while the Middle East & Africa are experiencing rising healthcare investments and awareness, driving the adoption of transdermal patches as a preferred drug delivery method.

The Transdermal Medical Patch Market is experiencing significant shifts due to global tariffs, geopolitical risks, and evolving supply chain dynamics. In Japan and South Korea, strategic investments in local production capabilities are being prioritized to mitigate tariff impacts and dependence on external suppliers. China is intensifying efforts in technological self-sufficiency, focusing on indigenous innovation amidst trade tensions, while Taiwan remains a pivotal player in the sector but faces geopolitical vulnerabilities. The global parent market is witnessing steady growth, driven by advancements in drug delivery systems and rising healthcare demands. By 2035, the market is expected to evolve with increased regional cooperation and innovation. Middle East conflicts continue to exert pressure on global supply chains and energy prices, indirectly influencing production costs and market strategies.

Key Trends and Drivers:

The transdermal medical patch market is experiencing robust growth fueled by technological advancements and increasing demand for non-invasive drug delivery systems. Key trends include the development of patches with enhanced permeability and controlled release mechanisms, offering improved patient compliance and therapeutic outcomes. The integration of micro-needles and iontophoresis in patch designs is also gaining traction, facilitating the delivery of a broader range of drugs. Drivers of this market include the rising prevalence of chronic diseases such as diabetes and cardiovascular conditions, which necessitate continuous and controlled medication delivery. The growing geriatric population, with its preference for pain-free and convenient treatment options, further propels market expansion. Additionally, the trend towards personalized medicine is encouraging the development of patches tailored to individual patient needs, enhancing the efficacy of treatments. Opportunities are abundant in emerging markets where healthcare infrastructure is rapidly improving, and access to advanced medical technologies is increasing. Companies investing in research and development to create innovative patch solutions are well-positioned to capitalize on this growing demand. Furthermore, the increasing focus on self-administration of medications is expected to drive the adoption of transdermal patches, providing a lucrative avenue for market participants.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Technology
  • 2.4 Key Market Highlights by Application
  • 2.5 Key Market Highlights by Material Type
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Functionality

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Single-layer Drug-in-Adhesive
    • 4.1.2 Multi-layer Drug-in-Adhesive
    • 4.1.3 Reservoir
    • 4.1.4 Matrix
    • 4.1.5 Vapor Patch
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Nicotine Patches
    • 4.2.2 Pain Relief Patches
    • 4.2.3 Hormonal Patches
    • 4.2.4 Cardiovascular Patches
    • 4.2.5 Neurological Patches
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 Electroporation
    • 4.3.2 Iontophoresis
    • 4.3.3 Microneedles
    • 4.3.4 Thermal Ablation
    • 4.3.5 Ultrasound
  • 4.4 Market Size & Forecast by Application (2020-2035)
    • 4.4.1 Pain Management
    • 4.4.2 Hormone Replacement Therapy
    • 4.4.3 Smoking Cessation
    • 4.4.4 Neurological Disorders
    • 4.4.5 Cardiovascular Disorders
  • 4.5 Market Size & Forecast by Material Type (2020-2035)
    • 4.5.1 Polymer
    • 4.5.2 Acrylic
    • 4.5.3 Silicone
    • 4.5.4 Polyisobutylene
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Clinics
    • 4.6.3 Home Care Settings
    • 4.6.4 Ambulatory Surgical Centers
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Adhesive
    • 4.7.2 Backing Layer
    • 4.7.3 Drug Layer
    • 4.7.4 Release Liner
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Manufacturing
    • 4.8.2 Packaging
    • 4.8.3 Quality Control
    • 4.8.4 Distribution
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Controlled Release
    • 4.9.2 Sustained Release
    • 4.9.3 Immediate Release

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Application
      • 5.2.1.5 Material Type
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Process
      • 5.2.1.9 Functionality
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Application
      • 5.2.2.5 Material Type
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Process
      • 5.2.2.9 Functionality
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Application
      • 5.2.3.5 Material Type
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Process
      • 5.2.3.9 Functionality
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Application
      • 5.3.1.5 Material Type
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Process
      • 5.3.1.9 Functionality
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Application
      • 5.3.2.5 Material Type
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Process
      • 5.3.2.9 Functionality
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Application
      • 5.3.3.5 Material Type
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Process
      • 5.3.3.9 Functionality
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Application
      • 5.4.1.5 Material Type
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Process
      • 5.4.1.9 Functionality
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Application
      • 5.4.2.5 Material Type
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Process
      • 5.4.2.9 Functionality
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Application
      • 5.4.3.5 Material Type
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Process
      • 5.4.3.9 Functionality
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Application
      • 5.4.4.5 Material Type
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Process
      • 5.4.4.9 Functionality
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Application
      • 5.4.5.5 Material Type
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Process
      • 5.4.5.9 Functionality
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Application
      • 5.4.6.5 Material Type
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Process
      • 5.4.6.9 Functionality
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Technology
      • 5.4.7.4 Application
      • 5.4.7.5 Material Type
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Process
      • 5.4.7.9 Functionality
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Application
      • 5.5.1.5 Material Type
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Process
      • 5.5.1.9 Functionality
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Application
      • 5.5.2.5 Material Type
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Process
      • 5.5.2.9 Functionality
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Application
      • 5.5.3.5 Material Type
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Process
      • 5.5.3.9 Functionality
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Application
      • 5.5.4.5 Material Type
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Process
      • 5.5.4.9 Functionality
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Application
      • 5.5.5.5 Material Type
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Process
      • 5.5.5.9 Functionality
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Application
      • 5.5.6.5 Material Type
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Process
      • 5.5.6.9 Functionality
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Application
      • 5.6.1.5 Material Type
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Process
      • 5.6.1.9 Functionality
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Application
      • 5.6.2.5 Material Type
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Process
      • 5.6.2.9 Functionality
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Application
      • 5.6.3.5 Material Type
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Process
      • 5.6.3.9 Functionality
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Application
      • 5.6.4.5 Material Type
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Process
      • 5.6.4.9 Functionality
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Application
      • 5.6.5.5 Material Type
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Process
      • 5.6.5.9 Functionality

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Hisamitsu Pharmaceutical
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Mylan
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Perrigo Company
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Teva Pharmaceutical Industries
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Noven Pharmaceuticals
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Actavis
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Endo Pharmaceuticals
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Lohmann Therapie Systeme
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Medherant
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Zosano Pharma
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Corium International
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Duro- Med Industries
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Nitto Denko
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Lifescience Plus
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Tapemark
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Adhex Pharma
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 4 P Therapeutics
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Pro Solus
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Transdermal Technologies
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 LTS Lohmann
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us